Decision: Favourable

Decisions Table

Study Title:

A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)

  • NREC Code:

    22-NREC-CT-148

  • Decision:

    Favourable

  • Meeting Date:

    21/09/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Prof Orla Hardiman

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Cytokinetics, Inc

Scroll to Top